argenx SE | ARGX - Operating Profit

Stock Price
663.80
Daily Change
-2.40 -0.36%
Monthly
8.29%
Yearly
22.74%
Q2 Forecast
651.81

argenx SE reported $371.14M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Qiagen NV USD 121.88M 15.41M Dec/2025
UCB EUR 1.29B 571M Dec/2025